Drugs / secretome - mesenchymal stem cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05122234 | Aug 2020 → Jul 2021 | COVID-19 | Indonesia University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | secretome - mesenchymal stem cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05122234 ↗ |
| Route | Intravenous | “The administration is done intravenously for 60 minutes.” NCT05122234 ↗ |